LPA and familial hyperaldosteronism: Comprehensive genetic analysis can delineate whether a person with hypercholesterolemia and high Lp(a) is due to monogenic FH and high Lp(a), which carries a very high ASCVD risk, versus someone with high Lp(a) that presents as clinical hypercholesterolemia.